Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Ratings
2 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Dr. Robert J. Hariri, M.D.,PhD$66.2M
Market Cap • 25/07/20242018
(há 6 anos)
2021
(3 years ago)
NASDAQ
Listagem
Florham Park
Sede • New Jersey225
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CELUSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.